Cargando…

Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas

Pheochromocytoma/paragangliomas (Pheo/PGL) are rare endocrine cancers with strong genetic background. Mutations in the SDHB subunit of succinate dehydrogenase (SDH) predispose patients to malignant disease with limited therapeutic options and poor prognosis. Using a host of cellular and molecular bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarkadi, Balazs, Meszaros, Katalin, Krencz, Ildiko, Canu, Letizia, Krokker, Lilla, Zakarias, Sara, Barna, Gabor, Sebestyen, Anna, Papay, Judit, Hujber, Zoltan, Butz, Henriett, Darvasi, Otto, Igaz, Peter, Doczi, Judit, Luconi, Michaela, Chinopoulos, Christos, Patocs, Attila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139890/ https://www.ncbi.nlm.nih.gov/pubmed/32150977 http://dx.doi.org/10.3390/cancers12030599

Ejemplares similares

Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma
por: Krokker, Lilla, et al.
Publicado: (2019)

Three Dimensional Cell Culturing for Modeling Adrenal and Pituitary Tumors
por: Krokker, Lilla, et al.
Publicado: (2021)

Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma
por: Sarkadi, Balazs, et al.
Publicado: (2021)

The SDHB Arg230His mutation causing familial paraganglioma alters glycolysis in a new Caenorhabditis elegans model
por: Saskői, Éva, et al.
Publicado: (2020)

Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors
por: Krokker, Lilla, et al.
Publicado: (2021)

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach
por: Sarkadi, Balazs, et al.
Publicado: (2022)

Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells
por: Petővári, Gábor, et al.
Publicado: (2019)

MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma
por: Turai, Peter Istvan, et al.
Publicado: (2021)

Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics
por: Krencz, Ildikó, et al.
Publicado: (2022)

A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1
por: Farkas, Henriette, et al.
Publicado: (2022)

Application of Multilayer Evidence for Annotation of C-Terminal BRCA2 Variants
por: Butz, Henriett, et al.
Publicado: (2021)

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
por: Huang, Yiqiang, et al.
Publicado: (2018)

Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma–Paraganglioma
por: Choi, Hye-Ryeon, et al.
Publicado: (2021)

Sunitinib in the therapy of malignant paragangliomas: report on the efficacy in a SDHB mutation carrier and review of the literature
por: Canu, Letizia, et al.
Publicado: (2016)

The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
por: Bayley, Jean-Pierre, et al.
Publicado: (2009)

SDHB-Associated Paraganglioma in a Pediatric Patient and Literature Review on Hereditary Pheochromocytoma-Paraganglioma Syndromes
por: Choat, Heather, et al.
Publicado: (2014)

Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas
por: Németh, K., et al.
Publicado: (2019)

Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2016)

Paraganglioma of the tongue with SDHB gene mutation in a patient with Graves’ disease
por: Duran Alvarez, Marcela Adriana, et al.
Publicado: (2019)

A Multifocal Paraganglioma in an African Male Due to an Underlying SDHB Mutation
por: Siddiqui, Nida Mishraz, et al.
Publicado: (2021)

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis
por: Su, Tingwei, et al.
Publicado: (2023)

Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma
por: Szabó, Borbála, et al.
Publicado: (2022)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
por: Bayley, Jean-Pierre, et al.
Publicado: (2006)

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas
por: Németh, Kinga, et al.
Publicado: (2018)

Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
por: Poplawski, NK, et al.
Publicado: (2012)

Low penetrance of a SDHB mutation in a large Dutch paraganglioma family
por: Hes, Frederik J, et al.
Publicado: (2010)

Nationwide study of patients with head and neck paragangliomas carrying SDHB germline mutations
por: Rijken, J. A., et al.
Publicado: (2018)

SUN-344 SDHB Immunostaining: Still an Indispensable Tool in Characterising Pheochromocytoma and Paraganglioma
por: Velusamy, Anand, et al.
Publicado: (2019)

Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma
por: Liu, Yang, et al.
Publicado: (2020)

SDHB-Associated Paraganglioma Syndrome in Africa—A Need for Greater Genetic Testing
por: Siddiqui, Nida, et al.
Publicado: (2021)

Transaminitis Evaluation Leads to the Incidental Diagnosis of Familial Paraganglioma Due to SDHB Mutation
por: Okafor, Anderson, et al.
Publicado: (2021)

FRI369 SDHB Hereditary Pheochromocytoma Paraganglioma Syndrome With Biochemically Silent Pheochromocytoma
por: Skariah, Annie M, et al.
Publicado: (2023)

Identification of a novel SDHB c.563 T > C mutation responsible for Paraganglioma syndrome and genetic analysis of the SDHB gene in China: a case report
por: Chen, Heye, et al.
Publicado: (2020)

Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa
por: Gordon, Debra M, et al.
Publicado: (2021)

A SDHB Variant of Unknown Significance in a Patient With a Cardiac Functional Paraganglioma
por: Carafone, Lindsay, et al.
Publicado: (2023)

Pituitary Carcinoma in a Patient with an SDHB Mutation
por: Tufton, Nicola, et al.
Publicado: (2017)

Circulating miRNA Increases the Diagnostic Accuracy of Chromogranin A in Metastatic Pancreatic Neuroendocrine Tumors
por: Kövesdi, Annamária, et al.
Publicado: (2020)

Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting
por: Dankó, Titanilla, et al.
Publicado: (2022)

Wnt-Signaling Regulated by Glucocorticoid-Induced miRNAs
por: Butz, Henriett, et al.
Publicado: (2021)

Context-Dependent Role of Glucocorticoid Receptor Alpha and Beta in Breast Cancer Cell Behaviour
por: Butz, Henriett, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nvvak50vm763li9inqmi30hlmr